{"nct_id":"NCT03276052","title":"A Phase I, Open-Label, Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide in Healthy Chinese Participants","status":"COMPLETED","status_verified_date":"2023-02","start_date":"2021-10-14","start_date_type":"ACTUAL","primary_completion_date":"2021-11-26","primary_completion_date_type":"ACTUAL","completion_date":"2021-11-26","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AZN"]}